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Abstract
Introduction: Continuous cardiac output monitoring is used for early detection of hemodynamic instability and
guidance of therapy in critically ill patients. Recently, the accuracy of pulse contour-derived cardiac output (PCCO)
has been questioned in different clinical situations. In this study, we examined agreement between PCCO and
transcardiopulmonary thermodilution cardiac output (COTCP) in critically ill patients, with special emphasis on
norepinephrine (NE) administration and the time interval between calibrations.
Methods: This prospective, observational study was performed with a sample of 73 patients (mean age, 63 ± 13
years) requiring invasive hemodynamic monitoring on a non-cardiac surgery intensive care unit. PCCO was
recorded immediately before calibration by COTCP. Bland-Altman analysis was performed on data subsets
comparing agreement between PCCO and COTCP according to NE dosage and the time interval between
calibrations up to 24 hours. Further, central artery stiffness was calculated on the basis of the pulse pressure to
stroke volume relationship.
Results: A total of 330 data pairs were analyzed. For all data pairs, the mean COTCP (±SD) was 8.2 ± 2.0 L/min.
PCCO had a mean bias of 0.16 L/min with limits of agreement of -2.81 to 3.15 L/min (percentage error, 38%) when
compared to COTCP. Whereas the bias between PCCO and COTCP was not significantly different between NE
dosage categories or categories of time elapsed between calibrations, interchangeability (percentage error <30%)
between methods was present only in the high NE dosage subgroup (≥0.1 μg/kg/min), as the percentage errors
were 40%, 47% and 28% in the no NE, NE < 0.1 and NE ≥ 0.1 μg/kg/min subgroups, respectively. PCCO was not
interchangeable with COTCP in subgroups of different calibration intervals. The high NE dosage group showed
significantly increased central artery stiffness.
Conclusions: This study shows that NE dosage, but not the time interval between calibrations, has an impact on
the agreement between PCCO and COTCP. Only in the measurements with high NE dosage (representing the
minority of measurements) was PCCO interchangeable with COTCP.
Introduction
Cardiac output (CO) monitoring in high-risk patients has
gained increasing interest because early detection of
hemodynamic instability can reduce morbidity in these
patients [1-3]. Investigators in several studies evaluating
goal-directed protocols have reported improved
outcomes due to immediate treatment to prevent or
resolve organ ischemia [4,5]. The PiCCOplus system
(Pulsion Medical Systems, Munich, Germany) allows
continuous CO measurement by pulse contour analysis
(PCCO). Calibration of PCCO is performed by intermit-
tent transcardiopulmonary thermodilution cardiac output
(COTCP). It has been demonstrated that PCCO agrees
with pulmonary artery thermodilution CO [6-8] and with
COTCP [9,10] in cardiac surgery patients. However, the
reliability of PCCO has been questioned in clinical
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epinephrine (NE) administration [11], changes in vascular
tone [12], increased intra-abdominal pressure [13] or
time interval between calibrations [14]. Therefore, the
clinician needs to consider these confounders when
interpreting PCCO values and prompting therapeutic
decisions.
T h ep r e s e n tp r o s p e c t i v eo b s ervational study investi-
gated a large group of critically ill patients with regard
to whether agreement between PCCO and COTCP is
affected by different NE dosages or by the time interval
between calibrations. On the basis of the existing litera-
ture, we generated the following two hypotheses: (1)
Increasing NE dosage results in decreased agreement
between PCCO and COTCP, and (2) increasing the time
interval between calibrations of PCCO results in
decreased agreement between PCCO and COTCP.
Only rare data are available about the usage of PCCO
calibrations in clinical practice. Therefore, we retrospec-
tively evaluated whether NE dosage or severity of dis-
ease as measured by the Acute Physiology and Chronic
Health Evaluation II score (APACHE II score) had an
influence on calibration frequency on our intensive care
unit (ICU).
Materials and methods
Patients
In this prospective observational study, critically ill
patients equipped with invasive hemodynamic monitor-
ing by the PiCCOplus system (version 6.0) on our non-
cardiac ICU between September 2007 and July 2008
were included. The study was approved by our institu-
tional review board in compliance with the Helsinki
Declaration (Ethics Committee of the University Hospi-
tal Schleswig-Holstein, Campus Kiel, Kiel, Germany).
Patients and/or relatives gave their informed consent for
the patients’ data to be used in the analysis. Invasive
hemodynamic monitoring was performed according to
the judgment of the attending physician on the ICU.
Exclusion criteria were cardiac arrhythmias, a perma-
nent pacemaker or any other mechanical cardiac sup-
port and known valvular heart disease.
Hemodynamic measurements
In all patients, a central venous catheter and a thermis-
tor-tipped arterial catheter (Pulsiocath; Pulsion Medical
Systems, Munich, Germany) inserted via femoral artery
were present upon enrollment. The PiCCO device uses
pulse contour analysis according to a modified algo-
rithm originally described by Wesseling et al.[ 1 5 ]t o
determine PCCO and is described in more detail else-
where [9]. This algorithm enables continuous calculation
of stroke volume (SV) by measuring the systolic portion
of the aortic pressure waveform and dividing the area
under the curve by the aortic compliance. Therefore,
t h eP i C C Od e v i c en e e d st ob ec a l i b r a t e db yC O TCP.
Calibrations were regularly performed by an ICU physi-
cian at defined time points (0:00 AM, 8:00 AM or 4:00
PM) with the patient in a supine position during a time
period without acute hemodynamic instability using
three subsequent boluses of 15 mL of ice-cold saline
injected into the central venous line as proposed by the
manufacturer [9]. During measurement, neither treat-
ment provoking hemodynamic changes nor change of
ventilation variables was performed. The dosage of vaso-
pressors was kept constant. Our institutional guideline
suggests calibration every 8 hours or before any major
change in therapy is initiated. Therefore, additional cali-
brations by the attending ICU physician were allowed at
any time. All hemodynamic data, including PCCO, cen-
tral venous pressure (CVP), mean arterial blood pressure
(MAP), pulse pressure (PP) (systolic minus diastolic aor-
tic pressure) and heart rate (HR) were recorded immedi-
ately before and after calibration by COTCP. Global end-
d i a s t o l i cv o l u m ei n d e x( G E D I) and systemic vascular
resistance index (SVRI) were derived upon thermodilu-
tion. SV was calculated as COTCP divided by heart rate.
The PP to SV (PP/SV) relationship was used to examine
the influence of NE dosage on central arterial stiffness
as reported previously [16]. Our ICU is equipped with a
patient data management system (PDMS) (CareSuite;
Picis Inc., Wakefield, MA, USA) capable of electronically
storing hemodynamic variables, including all single ther-
modilution calibrations, and ventilatory variables min-
ute-by-minute.
Statistical analysis
Statistical analysis was performed using the statistical
software R (R Foundation, Vienna, Austria [17]) and
GraphPad Prism 5.01 software (GraphPad Software Inc.,
San Diego, CA, USA). Data are reported as means ±
standard deviations (SD) unless otherwise specified. NE
subgroups were defined as no NE, low-dose NE
(<0.1 μg/kg/min) and high-dose NE (≥0.1 μg/kg/min)
according to the Sepsis-Related Organ Failure Assess-
ment score [18]. Subgroups of time interval elapsed
after the latest calibration were defined as <2 hours, 2
to 4 hours, 4 to 8 hours, 8 to 16 hours and 16 to 24
hours. Data subsets for hemodynamic variables, PP/SV
ratio and calibration interval were compared using an
unpaired two-tailed t-test. Comparison of PCCO and
COTCP was performed by using Bland-Altman statistics
for multiple observations per individual [19], calculating
mean differences between methods (bias) ±2 SD (limits
of agreement). Bias between subgroups was compared
using a t-test. The percentage error was calculated as
reported by Critchley and Critchley [20], and interchan-
geability between methods was assumed as a percentage
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que (COTCP) was analyzed according to the method
described by Cecconi et al. [21] from the three consecu-
tive bolus injections for calibration. To test whether
PCCO reflected changes (Δ)i nC O ,t h eΔPCCO
(PCCO - preceding COTCP) was analyzed against
ΔCOTCP (actual COTCP -p r e c e d i n gC O TCP) by linear
regression analysis including the first pair of measure-
ments of each patient. The influence of NE dosage and
the severity of the patient’s medical condition (APACHE
II score) on calibration frequency was analyzed using
the Spearman correlation for nonparametric data. P <
0.05 was considered statistically significant.
Results
Seventy-three patients were included in this study.
The median (interquartile range) APACHE II score of
all patients was 24 (range, 20 to 29) at the time of
inclusion. Detailed patient characteristics are given in
Table 1.
We obtained 330 data pairs. In 265 of 330 data pairs,
patients received mechanical ventilation with a mean
tidal volume of 8 ± 1 mL/kg, a mean fraction of inspired
oxygen of 0.6 ± 0.1, a mean peak airway pressure of 23
± 6 cmH2O and a mean positive end-expiratory pressure
o f9±3c m H 2O. In the remaining 65 data pairs,
patients breathed spontaneously and received oxygen via
face mask. Calibration interval was 9 ± 6 hours (range,
1 to 24 hours). The precision of the three bolus injec-
tion -COTCP values was 7%, according to the method of
Cecconi et al. [21].
Concerning the effect of NE dosage on the agreement
between PCCO and COTCP, 27 data pairs were excluded
from further analysis because of additional dobutamine
or epinephrine administration. In 161 of 303 data pairs,
NE was administered in doses ranging from 0.01 to 4.29
μg/kg/min. The hemodynamic data and calibration
intervals of different NE subgroups are presented in
Table 2.
Bias between NE subgroups did not differ significantly.
However, PCCO was interchangeable with COTCP only
during high NE dosage and not at low or no NE dosage.
T h er e s u l t so ft h eB l a n d - A l tman analysis are presented
in Table 3, and plots are given in Figure 1.
The coefficient of correlation values, r (95% confi-
dence interval (95% CI)), between ΔPCCO and ΔCOTCP
was 0.46 (95% CI, 0.25 to 0.64; P <0 . 0 0 1 )f o ra l l
patients, 0.19 (95% CI, -0.23 to 0.55; P = 0.36) for no
NE, 0.37 (95% CI, -0.09 to 0.70; P = 0.11) for NE <
0.1 μg/kg/min and 0.78 (95% CI, 0.53 to 0.91; P < 0.001)
for NE ≥ 0.1 μg/kg/min subgroups, respectively. In the
NE ≥ 0.1 μg/kg/min subgroup, a statistically significant
(P < 0.05) higher PP/SV relationship (arterial stiffness)
was observed compared to the no NE or NE < 0.1 μg/
kg/min subgroups, respectively (Figure 2).
The mean bias between PCCO and COTCP did not
depend on time elapsed from the preceding calibration.
However, in none of the subgroups did agreement
between PCCO and COTCP meet defined criteria for
interchangeability, as the percentage error was above
30% in all respective interval subgroups. The time-
related effect on agreement is presented in Table 3.
Individual bias during each interval, as well as mean
bias ± limits of agreement, is plotted in Figure 3.
On our ICU, we recorded a mean (±SD) time interval
after the preceding calibration of 9 ± 6 hours. In 151
(46%) recordings, the time interval exceeded the recom-
mended 8-hour interval. In 14 (4%) recordings, the time
i n t e r v a lw a sa sl o n ga s2 4h o u r s .T h et i m ei n t e r v a ld i d
not correlate with NE dosage or APACHE II score (r =
-0.04, P = 0.48; and r = -0.01, P = 0.41), respectively.
Discussion
In the present study, we have demonstrated an influence
of NE dosage on agreement of PCCO, as only during
high NE dosage the criteria of interchangeability with
COTCP were met. Time elapsed between calibrations did
not affect agreement between methods.
Goal-directed therapy in high-risk patients has been
shown to improve outcomes [4,5]. One essential
Table 1 Patient characteristics, medical history and
reason for instrumentation with PiCCO monitoring
system
a
Parameter Value
Patients, n 73
Mean age, yr ± SD 63 ± 13; (range, 21 to 82)
Sex (males/females) 53/20
Weight, kg ± SD 79 ± 14
Height, cm ± SD 175 ± 8
APACHE II score 24 (range, 7 to 45)
Medical history, n
None 6
Arterial hypertension 35
Chronic obstructive pulmonary disease 9
Coronary heart disease 7
Diabetes 12
Renal insufficiency 11
Reason for hemodynamic monitoring, n
Hypovolemia (major surgery) 19
Hypovolemia (major trauma) 5
Peritonitis 15
Pneumonia 7
Resuscitated from cardiac arrest 5
Septic shock 22
aData are means ± SD, absolute numbers or median (range). Multiple answers
are possible. APACHE II score, Acute Physiology and Chronic Health Evaluation
II score.
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ment was started, the better the outcome. Therefore,
continuous CO monitoring in critically ill patients is
needed. However, PCCO needs to be validated in a
large number of patients and during relevant conditions
to gain more insight into the mechanisms influencing
this variable. The present study compared PCCO and
COTCP in 73 ICU patients with several comorbidities.
Most previous studies compared PCCO with COTCP in
small series of patients during cardiac surgery [6,8,9,22].
Data from larger patient samples, however, are scarce.
The percentage error between PCCO and CO derived
by a thermodilution method varied between 26% and
50% in earlier studies [14,23]. Critchley and Critchley
[20] defined a percentage error of less than 30% to indi-
cate interchangeability. Accordingly, we found an accep-
table agreement of PCCO with COTCP only in data
subsets obtained with high NE dosage, although a per-
centage error of 28% is still reasonably high. However,
t h er e s u l t so ft h ep r e s e n ts t u d yt e n dt or e f u t eo u rf i r s t
hypothesis. Increasing NE dosage does not seem to be
associated with decreased agreement between PCCO
and COTCP, but rather with improved interchangeability.
PCCO further showed a better performance in tracking
changes in CO during increased NE dosage because the
coefficient of correlation between ΔPCCO and ΔCOTCP
was higher. Vascular tone seems to be an important
issue regarding the agreement of PCCO methods with a
reference method such as transcardiopulmonary ther-
modilution. Rodig et al. [12] described an increased bias
between PCCO and CO measured by thermodilution
after administration of phenylephrine. The observed
change of SVR >60% between calibrations may explain
their findings. A recent publication applying the same
PCCO software used in our study concluded that agree-
ment was not influenced by changes in SVR due to bet-
ter adaptation of the newer algorithm [14]. In the
present study, SVR was not different between NE sub-
groups. Therefore, we hypothesize that despite a com-
parable SVR, a differing compliance of the vascular tree
between subgroups of different NE dosages may explain
the different level of agreement. A higher NE dosage
may result in an increased central arterial stiffness and
therefore reduced arterial compliance [24], as recently
reported by Wittrock et al. [16]. In agreement with
these findings, high NE dosage resulted in a significantly
Table 2 Hemodynamic data and calibration interval of different norepinephrine subgroups
a
All No NE NE < 0.1 (μg/kg/min) NE ≥ 0.1 (μg/kg/min)
Parameter (n = 330) (n = 142) (n = 82) (n = 79)
Hemodynamics
CI (L/min·m
2) 4.3 ± 1.1 4.4 ± 1.0 4.3 ± 1.0 4.3 ± 1.2
MAP (mmHg) 81 ± 15 88 ± 16 80 ± 11
b 76 ± 13
b
HR (beats/min) 98 ± 19 94 ± 16 96 ± 18 105 ± 21
b,c
CVP (mmHg) 12 ± 5 11 ± 5 12 ± 5 13 ± 4
GEDI (mL/m
2) 791 ± 191 808 ± 213 794 ± 180 780 ± 171
SVRI (dyn·s/cm
5/m
2) 1,367 ± 413 1,435 ± 409 1,309 ± 379 1,274 ± 419
Calibration interval (min) 443 (234 to 784) 442 (243 to 761) 518 (247 to 821) 439 (200 to 914)
aData are given as means ± SD or medians (interquartile range);
bP < 0.05 vs. no NE;
cP < 0.05 vs. NE < 0.1. This table presents descriptive hemodynamic data
and calibration interval regarding norepinephrine (NE) dosage subgroups. CI, cardiac index; MAP, mean arterial pressure; HR, heart rate; CVP, central venous
pressure; GEDI, global end-diastolic volume index; SVRI, systemic vascular resistance index.
Table 3 Results of Bland-Altman analysis of PCCO vs. COTCP
a
Number of patients Mean Bias Limits of agreement Percentage error
Parameter (nall/npatient) (L/min) (L/min) (L/min) (%)
All 330/73 8.1 0.16 -2.81-3.15 38
No NE 142/44 8.41 0.16 -3.12-3.44 40
NE < 0.1 (μg/kg/min) 82/38 8.50 0.06 -3.88-4.00 47
NE ≥ 0.1 (μg/kg/min) 79/30 7.87 0.29 -1.83-2.42 28
b
Calibration interval 0 to 2 hours 36/25 8.00 0.25 -4.00-4.51 54
Calibration interval 2 to 4 hours 48/35 7.78 0.12 -3.37-3.60 46
Calibration interval 4 to 8 hours 95/41 8.21 0.09 -2.43-2.61 31
Calibration interval 8 to 16 hours 101/47 8.19 0.21 -3.17-3.59 42
Calibration interval 16 to 24 hours 50/28 8.06 0.23 -2.90-3.34 40
anall, number of measurement pairs for pulse contour-derived cardiac output (PCCO) and transcardiopulmonary thermodilution cardiac output (COTCP); npatient,
number of patients; mean, mean of all PCCO and COTCP measurements.
bInterchangeability according to Critchley and Critchley [20]. Bias and limits of agreement
were calculated according to the method of Bland and Altman [19].
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stiffness. Increasing arterial stiffness leads to a more
rigid vascular system and therefore may result in better
agreement between methods. It is conceivable in this
context that the vasculature of patients on high NE has
less oscillatory capacity, which limits changes in arterial
compliance and consequently on the deviation from the
compliance obtained upon calibration. In clinical prac-
tice, however, many patients may be treated with either
a low dose of NE or no NE, and according to our
results, PCCO is not interchangeable with COTCP in
these patients.
Our results do not show a time-related effect on the
agreement between PCCO and COTCP, thus refuting the
second hypothesis. The percentage error was above 30%
in all calibration interval subgroups. The manufacturer
recommends recalibration every 8 hours. Godje et al.[ 9 ]
reported an overall acceptable agreement up to 44
hours; however, they did not indicate the bias and per-
centage error of subsets regarding different calibration
intervals. Hamzaoui et al. [14] reported a percentage
error below 30% only within the first hour after calibra-
tion of PCCO, but up to 37% within a 6-hour calibra-
tion interval. These authors concluded that PCCO is
stable during a 1-hour period, and even changes in SVR
did not alter the agreement. These results would prompt
one to use hourly recalibration. Regarding our results,
time elapsed from preceding calibration did not deter-
mine the level of agreement, as individually good agree-
ment was observed up to 24 hours and individually poor
agreement occurred within a period of 2 hours after
calibration. Moreover, we found acceptable agreement
in patients who were administered a high NE dosage,
and thus had higher arterial stiffness, who had mean
calibration periods of 7 hours.
This study also examined the clinical use of calibrations
by using PiCCO technology. Our institutional guidelines
recommend a recalibration of the PiCCO system every 8
hours (three times daily), as well as before and after any
major change in therapy. We found that in only 54% of
recordings were institutional guidelines of recalibration
Figure 1 Bland-Altman plots of different norepinephrine (NE) subgroups. PCCO, pulse contour cardiac output; COTCP, transcardiopulmonary
thermodilution cardiac output; PE, percentage error; solid line, mean bias; dotted lines, limits of agreement.
Figure 2 Arterial stiffness. Pulse pressure (PP) to stroke volume
(SV) relationship (PP/SV) as a measure of central arterial stiffness
within the different norepinephrine (NE) dosage (μg/kg/min)
subsets. Data are means ± SD; *P < 0.05 vs. no NE;
#P < 0.05 vs. NE
< 0.1 μg/kg/min.
Figure 3 Bias in relation to time interval between calibrations.
Mean bias (boxes) ± limits of agreement and individual bias (circles)
expressed as percentage of COTCP between PCCO and COTCP in
subsets of different calibration intervals. Dotted lines illustrate
interchangeability (±30%).
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quency with APACHE II score or NE dosage, indicating
that calibration of PCCO may not be dependent on the
severity of critical illness. These findings are surprising,
since recalibration may increase agreement between
methods [13]. However, our results indicate that the time
interval between calibrations may not to be the most
important factor in determining PCCO accuracy; more-
over, therapy during calibrations seems to be important.
There are some limitations to our study. To avoid
additional risk due to a more invasive methodology of
CO measurement, we used the PiCCO integrated trans-
cardiopulmonary thermodilution instead of the pulmon-
ary artery thermodilution method as a reference
technique for PCCO as previously described [13,14].
The calibration interval was not strictly standardized to
measure the effect of NE dosage on calibration fre-
quency on our ICU.
Conclusions
This study demonstrates further limitations of the
PCCO method for the determination of continuous CO.
Only during high NE dosage (≥0.1 μg/kg/min) was
PCCO interchangeable with COTCP. Therefore, the
accuracy of PCCO measurement relies on important
clinical circumstances.
Key messages
￿ During clinical conditions, PCCO and COTCP mea-
surements cannot be used interchangeably in
patients who are either not on vasopressor treatment
or on a low dose of vasopressors.
￿ Acceptable agreement between the methods was
observed only during an increased dose of norepi-
nephrine, representing the minority of measure-
ments. Even then the limits of agreement were
rather large.
￿ The time interval between calibrations of PCCO
does not improve the reliability of PCCO within a
period of 24 hours.
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